The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
about
Kidney stone disease.Metabolism of fructose to oxalate and glycolateRecent advances in managing and understanding nephrolithiasis/nephrocalcinosisUrinary stone disease and obesity: Different pathologies sharing common biochemical mechanismsNew insights into the pathogenesis of renal calculiEndoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formersRole of insulin resistance in uric acid nephrolithiasisDiet-induced acidosis: is it real and clinically relevant?Triuret as a potential hypokalemic agent: Structure characterization of triuret and triuret-alkali metal adducts by mass spectrometric techniquesDietary acid load and metabolic acidosis in renal transplant recipientsMetabolic syndrome and associated urolithiasis in adults enrolled in a community-based health program.Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.Comparison of Nephrolithiasis Prevalence in Two Bottlenose Dolphin (Tursiops truncatus) Populations.Association Between Adiponectin and Insulin Resistance in Diabetic Urolithiasis.Serum uric acid level as a cardio-cerebrovascular event risk factor in middle-aged and non-obese Chinese men.Hypocitraturia in common bottlenose dolphins (Tursiops truncatus): assessing a potential risk factor for urate nephrolithiasisApplication of a new method for GWAS in a related case/control sample with known pedigree structure: identification of new loci for nephrolithiasisEffect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion.The relationship between insulin, insulin resistance, parathyroid hormone, cortisol, testosterone, and thyroid function tests in the presence of nephrolithiasis: a comprehensive analysisIncreased risk of acute coronary syndrome among patients with urinary stone disease: a nationwide population-based cohort study.Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.Metabolic basis for low urine pH in type 2 diabetes.Prevalence of kidney stones in the United States.Metabolic syndrome and chronic kidney disease: Current status and future directions.Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030Epidemiology of pediatric urolithiasisIdentification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.Correlation between ApoE gene polymorphisms and the occurrence of urolithiasis.Stone composition as a function of age and sex.Metabolic syndrome and the genesis of uric acid stones.Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosisPharmacology of stone diseaseRecent advances in the pathophysiology of nephrolithiasis.Clinical characteristics of potential kidney donors with asymptomatic kidney stonesMetabolic acidosis-induced insulin resistance and cardiovascular riskPossible Relationship between Metabolic Syndrome Traits and Nephrolithiasis: Incidence for 15 Years According to Gender.Does obesity or hyperuricemia influence lithogenic risk profile in children with urolithiasis?The association of metabolic syndrome and urolithiasisIs urolithiasis associated with increased levels of high sensitivity C-reactive protein and interleukin-6 in diabetic patients?Diabetes mellitus and the risk of urolithiasis: a meta-analysis of observational studies.
P2860
Q24536113-F3421558-BEDB-4AA6-A932-7DE49D1CEC43Q24631832-B4D2A30F-9653-4A52-A406-F4C0EEC6C760Q26748565-FECBECDD-D6F6-45A5-AC55-5C429B11903BQ26829240-C1F05F5B-30FE-4D12-95CF-CD3712754514Q27026371-17269357-A218-4947-9CFA-0AE0BDC4345BQ27303089-F8221CE9-800A-4A62-BF5B-838CFF194DEBQ27694312-D3AAF0F1-B9CE-40EE-8169-1C6495D8AB9AQ28267307-3A2A14E9-CBE0-4146-B742-7EF01ED9FD0EQ28661791-6066EB9C-E289-4BF3-B6B3-54DDAD489DAAQ28714263-91C91FF3-1D9D-416F-BA41-30EBC632D2F5Q30424026-12D63C21-4ECB-4CCD-AE45-9D27BC2FC713Q30434757-66DC3392-32FA-4317-A40D-478F2ABF9E15Q30448251-BBEEECD2-A0D7-40BF-B7B3-016D64FA21ACQ33580057-76EC8A6A-DACA-4097-AD61-C730D848CF5CQ33648378-DC68F9E3-555F-47F4-AA4A-49A088EF97F3Q33791178-C44260A6-AA18-46BF-B8AD-C8F73D0A4CE2Q33809374-E37EE952-BA44-498E-B38A-5DC4CB5420F5Q33818281-82598ECC-FFB9-4771-8AE9-DCC65EBEAA19Q33819928-A2A6610B-7BA8-487A-B053-69E5E712AB92Q33882842-82856EEB-D6C1-48B0-AF5F-FAA63241CBDEQ33912524-D58AA3DD-C082-489E-BCC6-10171B2BF16DQ33944756-247A9044-EDE4-4A11-976F-08499C431BA9Q34267948-1BE68BDA-A3C6-4101-89FE-845D64A17E7CQ34453266-19F0A7E3-1638-4202-9A24-E158B045F6D3Q34487788-0B2CC020-D5EF-4E33-9150-6AB5C701A7A1Q34553714-1E3E465C-411B-4A33-AECD-5CA33F1B341BQ34580630-C0A18AF2-83E5-46A5-B10A-B057BC9F2125Q34585370-C37E4BBC-E528-405D-BE0E-802DBFB30CF8Q34629795-86DFD62C-F6B1-4096-9401-3CD555E2FB34Q34645361-603707B3-A02E-4F0A-9DC6-4EA65F683135Q34695462-72306203-4F48-4D1D-910A-35385FAD9D61Q34936294-061034DD-CE6A-4FE5-804B-DD5A350B2A9EQ34936316-AA3598EA-5FDE-4762-BD85-264813649B80Q35134720-FE6E6AC9-D6C9-4165-8333-59B5D78D3F4AQ35163137-59D42922-87C6-4312-9F9A-FB8C900E412CQ35182403-A4BDD92E-B44C-4DBA-B829-525BAAD4DF9EQ35214625-5C35DDBB-A357-4181-AC58-F7F037BA2D85Q35271466-BBF40461-3067-4F57-99CB-20A8CC1AA8F1Q35548438-493DDE58-E516-4053-A30A-0EDF77282D2EQ35610072-1C61598C-1BCF-4E9C-AC84-22531B37C9AB
P2860
The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The metabolic syndrome and uri ...... station of insulin resistance.
@en
The metabolic syndrome and uri ...... station of insulin resistance.
@nl
type
label
The metabolic syndrome and uri ...... station of insulin resistance.
@en
The metabolic syndrome and uri ...... station of insulin resistance.
@nl
prefLabel
The metabolic syndrome and uri ...... station of insulin resistance.
@en
The metabolic syndrome and uri ...... station of insulin resistance.
@nl
P2093
P1433
P1476
The metabolic syndrome and uri ...... station of insulin resistance.
@en
P2093
Alberto V Cabo-Chan
Khashayar Sakhaee
Manisha Chandalia
Nicola Abate
Orson W Moe
P304
P356
10.1111/J.1523-1755.2004.00386.X
P407
P577
2004-02-01T00:00:00Z
P5875
P6179
1040739332